Randomized Controlled Trials

FDA Rejects Filing of Moderna’s mRNA Flu Vaccine Over Comparator Dispute

The agency said the Phase 3 control for seniors did not reflect the U.S. best standard of care, a rare procedural rebuke that Moderna disputes.